In conclusion, the mechanisms of CCL2 in inducing drug resistance in cancer are very complicated, and further pre-clinical studies and clinical trials should be considered to investigate whether targeting CCL2 could overcome anticancer drug resistance. Here, CCL2 is linked to cancer.